We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Randomized, Double-blind, Active-controlled, Study of Rivoglitazone in Type 2 Diabetes Mellitus

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00571519
Recruitment Status : Terminated (DSPD focussing on Study 301 to confirm clinical profile before proceeding.)
First Posted : December 12, 2007
Last Update Posted : February 8, 2013
Information provided by (Responsible Party):
Daiichi Sankyo, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : May 2008
  Study Completion Date : May 2008
  Certification or Request for Extension to Delay Results Submission: February 1, 2013